[O-08] 一般演題口演セッション08「神経筋接合部疾患 1」

[O-08-2] gMG患者を対象としたエフガルチギモド皮下注射剤ADAPT-SC+試験の中間解析結果

高橋 正紀¹, James F. Howard Jr², Yuebing Li³, Tuan Vu⁴, Denis Korobko⁵, Sophie Steeland⁶, Benjamin Van Hoorick⁶, Jana Podhorna⁶, Moana Hodari⁶, 槍沢 公明⁷, Francesco Sacca⁸, Jan L. De Bleecker⁹, Renato Mantegazza¹⁰ (1.大阪大学大学院医学系研究科 神経内科・脳卒中科, 2.The University of North Carolina, 3.Cleveland Clinic, 4.Department of Neurology, University of South Florida Morsani College of Medicine, 5.State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital", 6.argenx, 7.総合花巻病院 脳神経内科, 8.NRSO Department, Federico II University of Naples, 9.Ghent University Hospital, 10.Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta)